◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Entero Healthcare Solutions Limited (ENTERO) Financial History

Name: Entero Healthcare Solutions Limited (ENTERO) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Distribution · DATA UPDATED 2026-09-20

Entero Healthcare Solutions Limited (ENTERO) operates in the Medical Distribution industry and is headquartered in Mumbai, India with about 4,671 employees. Its market capitalization is roughly ₹75 billion. In the fiscal year ended 2026-03-31, ENTERO reported ₹65.4B in revenue and ₹1.2B in net income.

Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India.

Interactive charts & full statements →

ENTERO Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹65.4B	₹50.7B	₹38.9B	₹32.9B
Gross Profit	₹6.3B	₹4.6B	₹3.2B	₹2.6B
Operating Income (EBIT)	₹2.2B	₹1.4B	₹868M	₹398M
Net Income	₹1.2B	₹948M	₹391M	(₹116M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ENTERO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹19.4B	₹19.1B	₹17.1B	₹15.7B	₹14.0B	—	—
Gross Profit	₹2.2B	₹2.1B	₹1.7B	₹1.6B	₹1.4B	—	—
Operating Income (EBIT)	₹847M	₹712M	₹580M	₹522M	₹412M	—	—
Net Income	₹382M	₹280M	₹276M	₹316M	₹278M	—	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ENTERO Free Cash Flow History

ENTERO Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹36.0B	₹27.0B	₹23.4B	₹13.1B	—
Total Liabilities	₹18.5B	₹9.3B	₹7.0B	₹7.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ENTERO viewer.

Other Companies in Medical Distribution

9987 · Suzuken Co., Ltd. — JPY 350 billion
8129 · Toho Holdings Co., Ltd. — JPY 255 billion
7476 · AS ONE Corporation — JPY 182 billion
3151 · Vital KSK Holdings, Inc. — JPY 78 billion
1099 · Sinopharm Group Co. Ltd. — HK$47 billion
3183 · WIN-Partners Co., Ltd. — JPY 35 billion
0874 · Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited — HK$21 billion
7634 · Hoshi Iryo-Sanki Co., Ltd. — JPY 16 billion

← ENTA All “E” companies ENTG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.